Clinical observations and mechanistic insights of traditional Chinese medicine in the management of diabetic retinopathy

References

• Ai X, Yu P, Luo L, Sun J, Tao H, Wang X, Meng X. 2022. Berberis dictyophylla inhibits angiogenesis and apoptosis of diabetic retinopathy via suppressing HIF-1α/VEGF/DLL-4/Notch-1 pathway. J Ethnopharmacol. 296:115453. doi: 10.1016/j.jep.2022.115453.
   PubMed Web of Science ®Google Scholar
• Asahara T, Bauters C, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM. 1995. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation. 92(9 Suppl):II365–371. doi: 10.1161/01.cir.92.9.365.
   PubMed Web of Science ®Google Scholar
• Beltramo E, Porta M. 2013. Pericyte loss in diabetic retinopathy: mechanisms and consequences. Curr Med Chem. 20(26):3218–3225. doi: 10.2174/09298673113209990022.
   PubMed Web of Science ®Google Scholar
• Cai Y, Tu H, Wu C, Liu T, Chen S, Shen L, Xiao Q, Zhao S, Xu S, Lin W, et al. 2024. Therapeutic potential of elema-1,3,7(11),8-tetraen-8,12-lactam from Curcuma wenyujin on diabetic retinopathy via anti-inflammatory and anti-angiogenic pathways. J Ethnopharmacol. 318(Pt A):116843. doi: 10.1016/j.jep.2023.116843.
   PubMedGoogle Scholar
• Chen F. 2023. Effectiveness and mechanism analysis of Qi-Ming Granules combined with calcium hydroxybenzenesulfonate in the treatment of non-proliferative diabetic retinopathy. Practical Clin J Integrated Trad Chinese Western Med. 23:18–21. (Chinese)
   Google Scholar
• Chen P, Cao Y, Bao B, Zhang L, Ding A. 2017. Antioxidant capacity of Typha angustifolia extracts and two active flavonoids. Pharm Biol. 55(1):1283–1288. doi: 10.1080/13880209.2017.1300818.
   PubMed Web of Science ®Google Scholar
• Chen X, Zeng K, Xu M, Liu X, Hu X, Xu T, He B, Pan Y, Sun H, Wang S. 2019. P53-induced miR-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting VEGFA and HMGA2. Cell Death Dis. 10(2):131. doi: 10.1038/s41419-018-1188-3.
   PubMed Web of Science ®Google Scholar
• Choi HJ, Zhang H, Park H, Choi KS, Lee HW, Agrawal V, Kim YM, Kwon YG. 2015. Yes-associated protein regulates endothelial cell contact-mediated expression of angiopoietin-2. Nat Commun. 6(1):6943. doi: 10.1038/ncomms7943.
   PubMedGoogle Scholar
• Choudhry H, Harris AL. 2018. Advances in hypoxia-inducible factor biology. Cell Metab. 27(2):281–298. doi: 10.1016/j.cmet.2017.10.005.
   PubMed Web of Science ®Google Scholar
• Crabtree GS, Chang JS. 2021. Management of complications and vision loss from proliferative diabetic retinopathy. Curr Diab Rep. 21(9):33. doi: 10.1007/s11892-021-01396-2.
   PubMed Web of Science ®Google Scholar
• Cui Q, Qiu L, Xu N. 2019. Clinical observation on the treatment of non-proliferative diabetic retinopathy with deficiency of Qi and Yin and stagnation of veins and collaterals by Zhi-Xue-San-Yu-Ming-Mu Tang. Chin J Clin. 47:997–999. (Chinese)
   Google Scholar
• Cunha-Vaz J, Bernardes R, Lobo C. 2011. Blood-retinal barrier. Eur J Ophthalmol. 21 Suppl 6(6_suppl):S3–S9. doi: 10.5301/EJO.2010.6049.
   PubMedGoogle Scholar
• Cunha-Vaz JG. 1983. Studies on the pathophysiology of diabetic retinopathy. The blood-retinal barrier in diabetes. Diabetes. 32 Suppl 2(Supp_2):20–27. doi: 10.2337/diab.32.2.s20.
   PubMedGoogle Scholar
• Dai H, Dong Z, Zhang T, Jia L, Zhang Z, Fu X. 2016. Intervention effect of Chinese medicine compound PRD on retinal cell apoptosis in OLETF rats. Chin J Neuroanat. 32:67–72. (Chinese)
   Google Scholar
• Dai L, Shi W, Liang J, Ma G, Li Z. 2020. Clinical study on the non-proliferative stage of diabetic retinopathy by Tian-Jiang-Xue-Shuan-Tong Pills. Chin Med Modern Distance Edu China. 18:72–74. (Chinese)
   Google Scholar
• Dall TM, Narayan KM, Gillespie KB, Gallo PD, Blanchard TD, Solcan M, O’Grady M, Quick WW. 2014. Detecting type 2 diabetes and prediabetes among asymptomatic adults in the United States: modeling American Diabetes Association versus US Preventive Services Task Force diabetes screening guidelines. Popul Health Metr. 12(1):12. doi: 10.1186/1478-7954-12-12.
   PubMedGoogle Scholar
• Damert A, Ikeda E, Risau W. 1997. Activator-protein-1 binding potentiates the hypoxia-induciblefactor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells. Biochem J. 327 (Pt 2)(Pt 2):419–423. doi: 10.1042/bj3270419.
   PubMedGoogle Scholar
• Di S, Yao C, Qiao L, Li X, Pang B, Lin J, Wang J, Li M, Tong X. 2022. Exploration of the mechanisms underlying the beneficial effect of Luo-Tong Formula on retinal function in diabetic rats via the “gut microbiota-inflammation-retina” axis. Chin Med. 17(1):133. (Chinese) doi: 10.1186/s13020-022-00688-3.
   PubMed Web of Science ®Google Scholar
• Díaz-Coránguez M, Ramos C, Antonetti DA. 2017. The inner blood-retinal barrier: cellular basis and development. Vision Res. 139:123–137. doi: 10.1016/j.visres.2017.05.009.
   PubMed Web of Science ®Google Scholar
• Du A, Xie Y, Ouyang H, Lu B, Jia W, Xu H, Ji L. 2021. Si-Miao-Yong-An Decoction for diabetic retinopathy: a combined network pharmacological and in vivo approach. Front Pharmacol. 12:763163. doi: 10.3389/fphar.2021.763163.
   PubMed Web of Science ®Google Scholar
• Eissa LD, Ghobashy WA, El-Azab MF. 2021. Inhibition of thioredoxin-interacting protein and inflammasome assembly using verapamil mitigates diabetic retinopathy and pancreatic injury. Eur J Pharmacol. 901:174061. doi: 10.1016/j.ejphar.2021.174061.
   PubMed Web of Science ®Google Scholar
• Erickson KK, Sundstrom JM, Antonetti DA. 2007. Vascular permeability in ocular disease and the role of tight junctions. Angiogenesis. 10(2):103–117. doi: 10.1007/s10456-007-9067-z.
   PubMedGoogle Scholar
• Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA, Ying GS. 2020. Diabetic retinopathy preferred practice pattern. Ophthalmology. 127(1):P66–P145. doi: 10.1016/j.ophtha.2019.09.025.
   PubMed Web of Science ®Google Scholar
• Gao D, Guo Y, Li X, Li X, Li Z, Xue M, Ou Z, Liu M, Yang M, Liu S, et al. 2013. An aqueous extract of Radix astragali, Angelica sinensis, and Panax notoginseng is effective in preventing diabetic retinopathy. Evid Based Complement Alternat Med. 2013:578165–578111. doi: 10.1155/2013/578165.
   PubMed Web of Science ®Google Scholar
• Gao Y, Ji Y, Luo Y, Sun J, Sun G, Sun X. 2020. Ginsenoside Rg1 prevents early diabetic retinopathy via reducing retinal ganglion cell layer and inner nuclear layer cell apoptosis in db/db mice. Ann Transl Med. 8(5):232–232. doi: 10.21037/atm.2019.12.155.
   PubMed Web of Science ®Google Scholar
• Garner A. 1993. Histopathology of diabetic retinopathy in man. Eye (Lond). 7 (Pt 2)(2):250–253. doi: 10.1038/eye.1993.58.
   PubMedGoogle Scholar
• Guan X, Wang S, Gao Y. 2013. Clinical observation on 40 cases of diabetic macular oedema treated with homemade Chinese medicine Zheng-Yuan-Yun-Sheng Dripping Pills. China Practical Medicine. 8:22–23. (Chinese)
   PubMedGoogle Scholar
• Han J, Back SH, Hur J, Lin YH, Gildersleeve R, Shan J, Yuan CL, Krokowski D, Wang S, Hatzoglou M, et al. 2013. ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nat Cell Biol. 15(5):481–490. doi: 10.1038/ncb2738.
   PubMed Web of Science ®Google Scholar
• Hao Y, Gao X. 2022. Diosgenin protects retinal pigment epithelial cells from inflammatory damage and oxidative stress induced by high glucose by activating the AMPK/Nrf-2/HO-1 pathway. Immun Inflamm Dis. 10:e698.
   PubMed Web of Science ®Google Scholar
• He M, Long P, Guo L, Zhang M, Wang S, He H. 2019. Fu-Shi-Ming Capsules attenuate diabetic rat retina damage via antioxidation and anti-inflammation. Evid Based Complement Alternat Med. 2019:5376439–5376413. doi: 10.1155/2019/5376439.
   PubMed Web of Science ®Google Scholar
• Heitzig N, Brinkmann BF, Koerdt SN, Rosso G, Shahin V, Rescher U. 2017. Annexin A8 promotes VEGF-A driven endothelial cell sprouting. Cell Adh Migr. 11(3):275–287. doi: 10.1080/19336918.2016.1264559.
   PubMed Web of Science ®Google Scholar
• Heldin CH, Westermark B. 1999. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev. 79(4):1283–1316. doi: 10.1152/physrev.1999.79.4.1283.
   PubMed Web of Science ®Google Scholar
• Heng LZ, Comyn O, Peto T, Tadros C, Ng E, Sivaprasad S, Hykin PG. 2013. Diabetic retinopathy: pathogenesis, clinical grading, management and future developments. Diabet Med. 30(6):640–650. doi: 10.1111/dme.12089.
   PubMed Web of Science ®Google Scholar
• Hu Z, Liu X, Yang M. 2021. Evidence and potential mechanisms of Jin-Gui-Shen-Qi Wan as a treatment for type 2 diabetes mellitus: a systematic review and meta-analysis. Front Pharmacol. 12:699932. doi: 10.3389/fphar.2021.699932.
   PubMed Web of Science ®Google Scholar
• Huang H. 2020. Pericyte-endothelial interactions in the retinal microvasculature. Int J Mol Sci. 21(19):7413. doi: 10.3390/ijms21197413.
   PubMed Web of Science ®Google Scholar
• Huang SY, Jeng C, Kao SC, Yu JJ, Liu DZ. 2004. Improved haemorrheological properties by Ginkgo biloba extract (Egb 761) in type 2 diabetes mellitus complicated with retinopathy. Clin Nutr. 23(4):615–621. doi: 10.1016/j.clnu.2003.10.010.
   PubMed Web of Science ®Google Scholar
• Huo J, Duan JG, Liu LS, Zhang FW, Zhu KY, Sui JQ, Jian WY. 2022. Evaluation of individualized treatment of nonproliferative diabetic retinopathy: a multi-center, randomized, parallel-controlled study. J Tradit Chin Med. 42:90–95.
   PubMed Web of Science ®Google Scholar
• Jenkins AJ, Joglekar MV, Hardikar AA, Keech AC, O’Neal DN, Januszewski AS. 2015. Biomarkers in diabetic retinopathy. Rev Diabet Stud. 12(1–2):159–195. doi: 10.1900/RDS.2015.12.159.
   PubMedGoogle Scholar
• Jia H. 2014. Clinical study on the treatment of non-proliferative diabetic retinopathy with Zi-Yin-Yi-Qi-Tong-Luo Formula. Hebei J Trad Chinese Med. 36:1846–1848. (Chinese)
   Google Scholar
• Jia L, Dong Z, Dong W, Zhang T, Dai H, Zhang Z, Wang H. 2015. Interventional effects of the Chinese medicine bodhidharma dan on the expression of retinal glucose-regulated protein 78 and c/ebp homologous protein in OLETF rats. Lishizhen Med Materia Med Res. 26:2904–2907. (Chinese)
   Google Scholar
• Jin D, Zhang Y, Zhang Y, Huang W, Meng X, Yang F, Bao Q, Zhang M, Yang Y, Ni Q, et al. 2021. Efficacy and safety of Tang-Wang Prescription for type 2 non-proliferative diabetic retinopathy: a study protocol for a randomized controlled trial. Front Pharmacol. 12:594308. doi: 10.3389/fphar.2021.594308.
   PubMed Web of Science ®Google Scholar
• Lechner J, O’Leary OE, Stitt AW. 2017. The pathology associated with diabetic retinopathy. Vision Res. 139:7–14. doi: 10.1016/j.visres.2017.04.003.
   PubMed Web of Science ®Google Scholar
• Lee YM, Kim CS, Jo K, Sohn EJ, Kim JS, Kim J. 2015. Inhibitory effect of Samul-Tang on retinal neovascularization in oxygen-induced retinopathy. BMC Complement Altern Med. 15(1):271. doi: 10.1186/s12906-015-0800-7.
   PubMedGoogle Scholar
• Lee YM, Kim CS, Sohn E, Jo K, Lim HR, Kim SK, Kim JS, Kim J. 2014. Sipjeondaebo-Tang, a traditional herbal formula, inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy. Tohoku J Exp Med. 234(3):229–236. doi: 10.1620/tjem.234.229.
   PubMed Web of Science ®Google Scholar
• Lee YM, Lee YR, Kim CS, Jo K, Sohn E, Kim JS, Kim J. 2015. Effect of Guibi-Tang, a traditional herbal formula, on retinal neovascularization in a mouse model of proliferative retinopathy. Int J Mol Sci. 16(12):29900–29910. doi: 10.3390/ijms161226211.
   PubMed Web of Science ®Google Scholar
• Lefevere E, Van Hove I, Sergeys J, Steel DHW, Schlingemann R, Moons L, Klaassen I. 2022. PDGF as an important initiator for neurite outgrowth associated with fibrovascular membranes in proliferative diabetic retinopathy. Curr Eye Res. 47(2):277–286. doi: 10.1080/02713683.2021.1966479.
   PubMed Web of Science ®Google Scholar
• Lei X, Zhou Y, Ren C, Chen X, Shang R, He J, Dou J. 2018. Typhae pollen polysaccharides ameliorate diabetic retinal injury in a streptozotocin-induced diabetic rat model. J Ethnopharmacol. 224:169–176. doi: 10.1016/j.jep.2018.05.030.
   PubMed Web of Science ®Google Scholar
• Li B, Zhang DC, Li XW, Dong XN, Li WP, Li WZ. 2022a. Protective effect of ginsenoside Rg1 against diabetic retinopathy by inhibiting NLRP3 inflammasome in type 2 diabetic mice. China J Trad Chinese Med Pharm. 47:476–483. (Chinese)
   Google Scholar
• Li C, Miao X, Li F, Wang S, Liu Q, Wang Y, Sun J. 2017. Oxidative stress-related mechanisms and antioxidant therapy in diabetic retinopathy. Oxid Med Cell Longev. 2017:9702820–9702815. doi: 10.1155/2017/9702820.
   PubMed Web of Science ®Google Scholar
• Li CT, Wang HB, Xu BJ. 2013. A comparative study on anticoagulant activities of three Chinese herbal medicines from the genus Panax and anticoagulant activities of ginsenosides Rg1 and Rg2. Pharm Biol. 51(8):1077–1080. doi: 10.3109/13880209.2013.775164.
   PubMed Web of Science ®Google Scholar
• Li HL, Hao GM, Tang SJ, Sun HH, Fang YS, Pang X, Liu H, Ji Q, Wang XR, Tian JY, et al. 2021. Huo-Xue-Jie-Du Formula improves diabetic retinopathy in rats by regulating microRNAs. J Ethnopharmacol. 268:113616. doi: 10.1016/j.jep.2020.113616.
   PubMed Web of Science ®Google Scholar
• Li L. 2007. Treatment of simple diabetic retinopathy by adding flavour to Si-Wu Tang in 30 cases. Shanxi J Trad Chinese Med. (08):992–993.
   Google Scholar
• Li RL, Wang JX, Chai LJ, Guo H, Wang H, Chen L, Hu LM, Wang SX. 2020. Xue-Shuan-Tong Injection (lyophilized) alleviates streptozotocin-induced diabetic retinopathy in rats. Chin J Integr Med. 26(11):825–832. doi: 10.1007/s11655-020-3088-5.
   PubMed Web of Science ®Google Scholar
• Li S, Feng Y, Feng L. 2017. A preliminary study on the treatment of early diabetic retinopathy with Mu-Xue-Kang Capsules. J Hebei Trad Chinese Med Pharmacol. 32:30–32. (Chinese)
   Google Scholar
• Li S, Lu S, Wang L, Liu S, Zhang L, Du J, Wu Z, Huang X. 2023. Effects of amygdalin on ferroptosis and oxidative stress in diabetic retinopathy progression via the NRF2/ARE signaling pathway. Exp Eye Res. 234:109569. doi: 10.1016/j.exer.2023.109569.
   PubMed Web of Science ®Google Scholar
• Li T, Wang G. 2014. Computer-aided targeting of the PI3K/Akt/mTOR pathway: toxicity reduction and therapeutic opportunities. Int J Mol Sci. 15(10):18856–18891. doi: 10.3390/ijms151018856.
   PubMed Web of Science ®Google Scholar
• Li X, Yang Y, Song Y, Nie F, Fu C, Qin Y. 2022. Effect of Shuang-Dan-Ming-Mu capsules on diabetic retinopathy in rats via regulation of miRNAs. Diabetes Metab Syndr Obes. 15:3181–3194. doi: 10.2147/DMSO.S379611.
   PubMed Web of Science ®Google Scholar
• Li Y, Li X, Yuan J, Pan B. 2013. Expression of VEGF and PEDF in the retina of diabetic rats and blood-retinal barrier damage. Recent Adv Ophthalmol. 33:29–32. (Chinese)
   Google Scholar
• Lian F, Wu L, Tian J, Jin M, Zhou S, Zhao M, Wei L, Zheng Y, Wang Y, Zhang M, et al. 2015. The effectiveness and safety of a danshen-containing Chinese herbal medicine for diabetic retinopathy: a randomized, double-blind, placebo-controlled multicenter clinical trial. J Ethnopharmacol. 164:71–77. doi: 10.1016/j.jep.2015.01.048.
   PubMed Web of Science ®Google Scholar
• Liang D, Qi Y, Liu L, Chen Z, Tang S, Tang J, Chen N. 2023. Jin-Gui-Shen-Qi Wan ameliorates diabetic retinopathy by inhibiting apoptosis of retinal ganglion cells through the Akt/HIF-1α pathway. Chin Med. 18(1):130. doi: 10.1186/s13020-023-00840-7.
   PubMed Web of Science ®Google Scholar
• Liang Y, Zeng Y, Zhu Z, Jiang Q, Hou Y, Wang X, Lai X, Li X, Li Q. 2020. Study on the effect and mechanism of the Tibetan medicine Ji-Kan-Ming-Mu Formula on rats with diabetic retinopathy. Chinese J Modern Appl Pharm. 37:1281–1289. (Chinese)
   Google Scholar
• Liao WL, Huang CP, Wang HP, Lei YJ, Lin HJ, Huang YC. 2023. Diosgenin, a natural steroidal sapogenin, alleviates the progression of diabetic retinopathy in diabetic mice. In Vivo. 37(2):661–666. doi: 10.21873/invivo.13126.
   PubMed Web of Science ®Google Scholar
• Lin HD, Lee YC, Chiang CY, Lin YJ, Shih CY, Tsai RK, Lin PY, Lin SZ, Ho TJ, Huang CY. 2023. Protective effects of Scoparia dulcis L. extract on high glucose-induced injury in human retinal pigment epithelial cells. Front Nutr. 10:1085248. doi: 10.3389/fnut.2023.1085248.
   PubMed Web of Science ®Google Scholar
• Liu G, Liu A, Zhen Y, Xu Z, Jin W, Zhao L. 2013. Effects of adding Bu-Yang-Huan-Wu Tang on perivascular cell apoptosis in retinal microvessels of diabetic rats. J Beijing Univ Trad Chinese Med. 36:178–182. (Chinese)
   Google Scholar
• Liu L, Zuo Z, Lu S, Liu A, Liu X. 2017. Naringin attenuates diabetic retinopathy by inhibiting inflammation, oxidative stress and NF-κB activation in vivo and in vitro. Iran J Basic Med Sci. 20(7):813–821. doi: 10.22038/IJBMS.2017.9017.
   PubMed Web of Science ®Google Scholar
• Liu M, Pan Q, Chen Y, Yang X, Zhao B, Jia L, Zhu Y, Zhang B, Gao X, Li X, et al. 2015. Administration of Danhong Injection to diabetic db/db mice inhibits the development of diabetic retinopathy and nephropathy. Sci Rep. 5(1):11219. doi: 10.1038/srep11219.
   PubMedGoogle Scholar
• Liu QP, Chen YY, Yu YY, An P, Xing YZ, Yang HX, Zhang YJ, Rahman K, Zhang L, Luan X, et al. 2022. Bie-Jia-Ruan-Mai-Tang, a Chinese medicine formula, inhibits retinal neovascularization in diabetic mice by inducing the apoptosis of retinal vascular endothelial cells. Front Cardiovasc Med. 9:959298. doi: 10.3389/fcvm.2022.959298.
   PubMed Web of Science ®Google Scholar
• Luo D, Qin Y, Yuan W, Deng H, Zhang Y, Jin M. 2015. Compound Danshen Dripping Pill for treating early diabetic retinopathy: a randomized, double-dummy, double-blind study. Evid Based Complement Alternat Med. 2015:539185–539187. doi: 10.1155/2015/539185.
   PubMed Web of Science ®Google Scholar
• Luo Y, Dong X, Lu S, Gao Y, Sun G, Sun X. 2021. Gypenoside XVII alleviates early diabetic retinopathy by regulating Müller cell apoptosis and autophagy in db/db mice. Eur J Pharmacol. 895:173893. doi: 10.1016/j.ejphar.2021.173893.
   PubMed Web of Science ®Google Scholar
• Ma D, Xie X, Zhang M, Wan L. 2014. The effect of kidney tonics and blood activators on retinal ganglion cell viability and glutamine synthetase activity in hyperglycaemic and/or hypoxic states. Recent Adv Ophthalmol. 34:510–514. (Chinese)
   Google Scholar
• Ma D, Xie X, Zhang M, Wan L. 2015. Effects of renal activators on glutamate metabolism in co-cultured retinal ganglion cells and Müller cells under hyperglycaemic and/or hypoxic conditions. Recent Adv Ophthalmol. 35:419–423. (Chinese)
   Google Scholar
• Madsen-Bouterse SA, Kowluru RA. 2008. Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Rev Endocr Metab Disord. 9(4):315–327. doi: 10.1007/s11154-008-9090-4.
   PubMed Web of Science ®Google Scholar
• McDowell RE, Barabas P, Augustine J, Chevallier O, McCarron P, Chen M, McGeown JG, Curtis TM. 2018. Müller glial dysfunction during diabetic retinopathy in rats is reduced by the acrolein-scavenging drug, 2-hydrazino-4,6-dimethylpyrimidine. Diabetologia. 61(12):2654–2667. doi: 10.1007/s00125-018-4707-y.
   PubMed Web of Science ®Google Scholar
• Mei X, Zhang T, Ouyang H, Lu B, Wang Z, Ji L. 2019. Scutellarin alleviates blood-retina-barrier oxidative stress injury initiated by activated microglia cells during the development of diabetic retinopathy. Biochem Pharmacol. 159:82–95. doi: 10.1016/j.bcp.2018.11.011.
   PubMed Web of Science ®Google Scholar
• Mei XY, Zhou LY, Zhang TY, Lu B, Ji LL. 2017. Scutellaria barbata attenuates diabetic retinopathy by preventing retinal inflammation and the decreased expression of tight junction protein. Int J Ophthalmol. 10(6):870–877. doi: 10.18240/ijo.2017.06.07.
   PubMed Web of Science ®Google Scholar
• Miura G. 2023. Visual evoked potentials for the detection of diabetic retinal neuropathy. Int J Mol Sci. 24(8):7361. doi: 10.3390/ijms24087361.
   PubMed Web of Science ®Google Scholar
• Mohamed Q, Gillies MC, Wong TY. 2007. Management of diabetic retinopathy: a systematic review. JAMA. 298(8):902–916. doi: 10.1001/jama.298.8.902.
   PubMed Web of Science ®Google Scholar
• Mouly P, Gaydou EM, Estienne J. 1993. Column liquid chromatographic determination of flavanone glycosides in citrus. Application to grapefruit and sour orange juice adulterations. J Chromatogr. 634(1):129–134. doi: 10.1016/0021-9673(93)80321-x.
   PubMed Web of Science ®Google Scholar
• Mrugacz M, Bryl A, Zorena K. 2021. Retinal vascular endothelial cell dysfunction and neuroretinal degeneration in diabetic patients. J Clin Med. 10(3):458. doi: 10.3390/jcm10030458.
   PubMed Web of Science ®Google Scholar
• Nulahou A, Wang Y, Wang X, Gao Y. 2018. Study on the efficacy of Yuan-Qi-Qu-Yu Formula in the treatment of non-proliferative diabetic retinopathy. Shanxi J Trad Chinese Med. 39:322–324. (Chinese)
   Google Scholar
• Polley S, Passos DO, Huang DB, Mulero MC, Mazumder A, Biswas T, Verma IM, Lyumkis D, Ghosh G. 2016. Structural basis for the activation of IKK1/α. Cell Rep. 17(8):1907–1914. doi: 10.1016/j.celrep.2016.10.067.
   PubMed Web of Science ®Google Scholar
• Rangasamy S, McGuire PG, Das A. 2012. Diabetic retinopathy and inflammation: novel therapeutic targets. Middle East Afr J Ophthalmol. 19(1):52–59. doi: 10.4103/0974-9233.92116.
   PubMedGoogle Scholar
• Rathnasamy G, Foulds WS, Ling EA, Kaur C. 2019. Retinal microglia - a key player in healthy and diseased retina. Prog Neurobiol. 173:18–40. doi: 10.1016/j.pneurobio.2018.05.006.
   PubMed Web of Science ®Google Scholar
• Ren J, Wang Y, Liu X, Sun L, Yang L, Wu L, Lian F, Wei Q, Wei L, Yu J, et al. 2024. Randomised, double-blind, multi-centre phase III clinical trial of Tong-Luo-Ming-Mu Capsules for the treatment of diabetic retinopathy with blood stasis, Qi and Yin deficiency evidence. Chinese J Exper Trad Med Formulae. 30:170–178. (Chinese)
   Google Scholar
• Ren P, Hu H, Zhang R. 2000. Observation on the efficacy of puerarin in treating diabetic retinopathy. Chinese J Integrated Trad Western Med. 20:574–576. (Chinese)
   Google Scholar
• Rossino MG, Dal Monte M, Casini G. 2019. Relationships between neurodegeneration and vascular damage in diabetic retinopathy. Front Neurosci. 13:1172. doi: 10.3389/fnins.2019.01172.
   PubMed Web of Science ®Google Scholar
• Scanlon PH. 2017. The English National Screening Programme for diabetic retinopathy 2003–2016. Acta Diabetol. 54(6):515–525. doi: 10.1007/s00592-017-0974-1.
   PubMed Web of Science ®Google Scholar
• Senda T, Mita S, Kaneda K, Kikuchi M, Akaike A. 1998. Effect of SA4503, a novel sigma1 receptor agonist, against glutamate neurotoxicity in cultured rat retinal neurons. Eur J Pharmacol. 342(1):105–111. doi: 10.1016/s0014-2999(97)01450-7.
   PubMed Web of Science ®Google Scholar
• Shi W, Zhang G, Xue Q, Wang X, Wei X, Zhang T, Yu A, Liu Y, Shi Z. 2019. Clinical observation on the treatment of diabetic retinopathy by Sheng-Qing-Jiang-Zhuo-Tong-Luo-Ming-Mu Formula. Hebei J Trad Chinese Med. 41:362–366. (Chinese)
   Google Scholar
• Shu X, Hu Y, Huang C, Wei N. 2021. Nimbolide ameliorates the streptozotocin-induced diabetic retinopathy in rats through the inhibition of TLR4/NF-κB signaling pathway. Saudi J Biol Sci. 28(8):4255–4262. doi: 10.1016/j.sjbs.2021.06.039.
   PubMed Web of Science ®Google Scholar
• Simó R, Hernández C. 2023. What else can we do to prevent diabetic retinopathy? Diabetologia. 66(9):1614–1621. doi: 10.1007/s00125-023-05940-5.
   PubMed Web of Science ®Google Scholar
• Sun H, Breslin JW, Zhu J, Yuan SY, Wu MH. 2006. Rho and Rock signaling in VEGF-induced microvascular endothelial hyperpermeability. Microcirculation. 13(3):237–247. doi: 10.1080/10739680600556944.
   PubMed Web of Science ®Google Scholar
• Sun H, Jiang H. 2013. Effect of Da-Ming Drink on LDL in background diabetic retinopathy. Acta Chinese Med Pharmacol. 41:138–139. (Chinese)
   Google Scholar
• Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, et al. 2022. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 183:109119. doi: 10.1016/j.diabres.2021.109119.
   PubMed Web of Science ®Google Scholar
• Sun WJ, An XD, Zhang YH, Zhao XF, Sun YT, Yang CQ, Kang XM, Jiang LL, Ji HY, Lian FM. 2023. The ideal treatment timing for diabetic retinopathy: the molecular pathological mechanisms underlying early-stage diabetic retinopathy are a matter of concern. Front Endocrinol (Lausanne). 14:1270145. doi: 10.3389/fendo.2023.1270145.
   PubMed Web of Science ®Google Scholar
• Tang K, Qin W, Wei R, Jiang Y, Fan L, Wang Z, Tan N. 2022. Ginsenoside Rd ameliorates high glucose-induced retinal endothelial injury through AMPK-STRT1 interdependence. Pharmacol Res. 179:106123. doi: 10.1016/j.phrs.2022.106123.
   PubMed Web of Science ®Google Scholar
• Taylor S, Srinivasan B, Wordinger RJ, Roque RS. 2003. Glutamate stimulates neurotrophin expression in cultured Müller cells. Brain Res Mol Brain Res. 111(1–2):189–197. doi: 10.1016/s0169-328x(03)00030-5.
   PubMedGoogle Scholar
• Tu W, Wang H, Li S, Liu Q, Sha H. 2019. The anti-inflammatory and anti-oxidant mechanisms of the Keap1/Nrf2/ARE signaling pathway in chronic diseases. Aging Dis. 10(3):637–651. doi: 10.14336/AD.2018.0513.
   PubMed Web of Science ®Google Scholar
• Tzekov R, Arden GB. 1999. The electroretinogram in diabetic retinopathy. Surv Ophthalmol. 44(1):53–60. doi: 10.1016/s0039-6257(99)00063-6.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang L, Dong Z, Shi J, Wang Y, Fu X, Zhang T, Dong W. 2019. Effects of the Chinese medicine bodhidharma on visual field and electrophysiology in patients with simple diabetic retinopathy. Chinese J Difficult and Complicated Cases. 18:1035–1038. (Chinese)
   Google Scholar
• Wang J, Ma Q, Li Y, Li P, Wang M, Wang T, Wang C, Wang T, Zhao B. 2020. Research progress on traditional Chinese medicine syndromes of diabetes mellitus. Biomed Pharmacother. 121:109565. doi: 10.1016/j.biopha.2019.109565.
   PubMed Web of Science ®Google Scholar
• Wang J, Yao Y, Liu X, Wang K, Zhou Q, Tang Y. 2019. Protective effects of Lycium barbarum polysaccharides on blood-retinal barrier via ROCK1 pathway in diabetic rats. Am J Transl Res. 11(10):6304–6315.
   PubMed Web of Science ®Google Scholar
• Wang L, Wang N, Tan HY, Zhang Y, Feng Y. 2015. Protective effect of a Chinese medicine formula He-Ying-Qing-Re Formula on diabetic retinopathy. J Ethnopharmacol. 169:295–304. doi: 10.1016/j.jep.2015.04.031.
   PubMed Web of Science ®Google Scholar
• Wang N, Wang L, Zhang C, Tan HY, Zhang Y, Feng Y. 2021. Berberine suppresses advanced glycation end products-associated diabetic retinopathy in hyperglycemic mice. Clin Transl Med. 11(11):e569. doi: 10.1002/ctm2.569.
   PubMed Web of Science ®Google Scholar
• Wang N, Zhang C, Xu Y, Tan HY, Chen H, Feng Y. 2021. Berberine improves insulin-induced diabetic retinopathy through exclusively suppressing Akt/mTOR-mediated HIF-1α/VEGF activation in retina endothelial cells. Int J Biol Sci. 17(15):4316–4326. doi: 10.7150/ijbs.62868.
   PubMed Web of Science ®Google Scholar
• Wang W, Lo ACY. 2018. Diabetic retinopathy: pathophysiology and treatments. Int J Mol Sci. 19(6):1816. doi: 10.3390/ijms19061816.
   PubMed Web of Science ®Google Scholar
• Wang X, Wu J, Zhang Z, Niu Y, Chen W, Wang Y. 2023. Efficacy of Qing-Gan-Ming-Shi Tang in the treatment of mild to moderate non-proliferative diabetic retinopathy and its effect on serum 25 hydroxyvitamin D, cystatin C and thrombomodulin. Hebei J Trad Chinese Med. 45:765–769. (Chinese)
   Google Scholar
• Wang Y, He J, Gao Y, Nulahou A. 2019. Randomised controlled observation on the efficacy of Yuan-Qi-Qu-Yu Formula in the treatment of proliferative diabetic retinopathy after vitrectomy. World Chinese Med. 14:718–721. (Chinese)
   Google Scholar
• Wang Y, Sun X, Xie Y, Du A, Chen M, Lai S, Wei X, Ji L, Wang C. 2023. Panax notoginseng saponins alleviate diabetic retinopathy by inhibiting retinal inflammation: association with the NF-κB signaling pathway. J Ethnopharmacol. 319(Pt 1):117135. doi: 10.1016/j.jep.2023.117135.
   PubMedGoogle Scholar
• Wang Z, Zhang X, Liu H. 2023. Clinical study on the treatment of diabetic retinopathy with Da-Ming Drink. J New Chinese Med. 55:114–117. (Chinese)
   Google Scholar
• Wat N, Wong RL, Wong IY. 2016. Associations between diabetic retinopathy and systemic risk factors. Hong Kong Med J. 22(6):589–599. doi: 10.12809/hkmj164869.
   PubMed Web of Science ®Google Scholar
• Wei L, Sun X, Fan C, Li R, Zhou S, Yu H. 2022. The pathophysiological mechanisms underlying diabetic retinopathy. Front Cell Dev Biol. 10:963615. doi: 10.3389/fcell.2022.963615.
   PubMed Web of Science ®Google Scholar
• Wei Q, Wei Y, Luo D, Xu Y. 2014. Experimental study on the prevention and treatment of early retinopathy in diabetic rats by traditional Chinese medicine Tang-Luo-Tong using the method of tonifying the kidney and activating blood flow. Clin J Chinese Med. 6(23):1–3 + 6. (Chinese)
   Google Scholar
• Wong TY, Cheung CM, Larsen M, Sharma S, Simó R. 2016. Diabetic retinopathy. Nat Rev Dis Primers. 2(1):16012. doi: 10.1038/nrdp.2016.12.
   PubMedGoogle Scholar
• Wu X, Mu L, Dong Z, Wu J, Zhang S, Su J, Zhang Y. 2023. Hu-Zhang-Qing-Mai Formula anti-oxidative stress alleviates diabetic retinopathy: network pharmacology analysis and in vitro experiment. Medicine (Baltimore). 102(36):e35034. doi: 10.1097/MD.0000000000035034.
   PubMedGoogle Scholar
• Wu Y. 2017. Liu-Wei-Di-Huang Pills combined with Ginkgo biloba to prevent early retinopathy in type 2 diabetes mellitus. Int Eye Sci. 17:1127–1129. (Chinese)
   Google Scholar
• Wu Z, Yan H, Ge D, Wang Q, Yan J, Gong X, Song X. 2018. Exploration of the mechanism of prevention and treatment of retinal ganglion cell injury in vitro under high glucose by Me-Meng-Hua formulae. J Trad Chinese Ophthalmol. 28:297–302. (Chinese)
   Google Scholar
• Xing W, Song Y, Li H, Wang Z, Wu Y, Li C, Wang Y, Liu Y, Wang W, Han J. 2019. Fufang Xueshuantong protects retinal vascular endothelial cells from high glucose by targeting YAP. Biomed Pharmacother. 120:109470. doi: 10.1016/j.biopha.2019.109470.
   PubMed Web of Science ®Google Scholar
• Xu J, Chen LJ, Yu J, Wang HJ, Zhang F, Liu Q, Wu J. 2018. Involvement of advanced glycation end products in the pathogenesis of diabetic retinopathy. Cell Physiol Biochem. 48(2):705–717. doi: 10.1159/000491897.
   PubMedGoogle Scholar
• Yang J, Duan J. 2007. Effect of Astragalus membranaceus extract on pericytes of bovine retinal capillaries cultured in vitro in high glucose culture. Int Eye Sci. 2007:685–687.
   Google Scholar
• Yang X, Huang Z, Xu M, Chen Y, Cao M, Yi G, Fu M. 2023. Autophagy in the retinal neurovascular unit: new perspectives into diabetic retinopathy. J Diabetes. 15(5):382–396. doi: 10.1111/1753-0407.13373.
   PubMed Web of Science ®Google Scholar
• Yang Y, Jiang G, Huang R, Liu Y, Chang X, Fu S. 2023. Targeting the NLRP3 inflammasome in diabetic retinopathy: from pathogenesis to therapeutic strategies. Biochem Pharmacol. 212:115569. doi: 10.1016/j.bcp.2023.115569.
   PubMed Web of Science ®Google Scholar
• Yi J. 2013. Clinical study on 42 cases of simple diabetic retinopathy treated with glucose-reducing and brightening soup. Forum Trad Chinese Med. 28:26–27. (Chinese)
   Google Scholar
• Yi J, Zhang S, Wan Y, Zhang J, Xiao J, Du W, Zeng X. 2019. A preliminary study of the clinical efficacy and anti-inflammatory mechanism of Chinese herbal remedies in patients with diabetic retinopathy. Chinese J Microcirculation. 29:51–54. (Chinese)
   Google Scholar
• Yu C, Zhao J, Yang D, Du X, Wu J, You L, Fang Z. 2020. Preventive effect of astragaloside on retinopathy in diabetic rats and its effect on oxidative stress pathway. Chinese Arch Trad Chinese Med. 38:194–197 + 292. (Chinese)
   Google Scholar
• Yu Z, Gong C, Lu B, Yang L, Sheng Y, Ji L, Wang Z. 2015. Dendrobium chrysotoxum Alleviates diabetic retinopathy by preventing retinal inflammation and tight junction protein decrease. J Diabetes Res. 2015:518317–518310. doi: 10.1155/2015/518317.
   PubMed Web of Science ®Google Scholar
• Yu Z, Lu B, Sheng Y, Zhou L, Ji L, Wang Z. 2015. Andrographolide ameliorates diabetic retinopathy by inhibiting retinal angiogenesis and inflammation. Biochim Biophys Acta. 1850(4):824–831. doi: 10.1016/j.bbagen.2015.01.014.
   PubMed Web of Science ®Google Scholar
• Yuan L, Zhang N, Liu S, Li T, Ren Q, Yang R, Liu S, Shi K, Meng X. 2023. Regulation of lnc RNA malat1 and Wnt/β-catenin pathway by Qi-Huang-Yi-Shen Formula inhibits epithelial-mesenchymal transition in rats with diabetic retinopathy. China J Trad Chinese Med Pharm. 38:2403–2408. (Chinese)
   Google Scholar
• Zhang C, Xu Y, Tan HY, Li S, Wang N, Zhang Y, Feng Y. 2018. Neuroprotective effect of He-Ying-Qing-Re Formula on retinal ganglion cell in diabetic retinopathy. J Ethnopharmacol. 214:179–189. doi: 10.1016/j.jep.2017.12.018.
   PubMed Web of Science ®Google Scholar
• Zhang M, Li C, Xue B, Lu J, Qin Y, Liu F, Yu Y. 2019. Effects of an empirical formula for benefiting Qi and nourishing Yin on visual electrophysiology in non-proliferative diabetic retinopathy. J Trad Chinese Ophthalmol. 29:184–187. +196. (Chinese)
   Google Scholar
• Zhang N, Xu J, Zhao J, Li T, Han J, Xiao C, Cao X, Wang Z. 2018. Therapeutic efficacy of vision clear drink on patients with stasis-heat obstruction type cataract combined with non-proliferative stage diabetic retinopathy. China J Trad Chinese Med Pharm. 33:386–389. (Chinese)
   Google Scholar
• Zhang X, Zhao B, Yang L, Tian Y, Liu X. 2013. A randomised double-blind controlled study of Tong-Luo-Ming-Mu Capsules in the treatment of diabetic retinopathy. Western J Trad Chinese Med. 26:88–90. (Chinese)
   Google Scholar
• Zhang Y, Wang L, Su W, Wang S, Yang S. 2020. Clinical study on the treatment of diabetic retinopathy with blood deficiency and collaterals blockage by Xi-Shi Drink. Trad Chinese Med J. 19:47–49 + 43. (Chinese)
   Google Scholar
• Zhang Z. 2016. Clinical efficacy of Yi-Qi-Tong-Luo Decoction in the treatment of diabetic retinopathy IV. World Latest Med Inform. 16:202–+205. (Chinese)
   Google Scholar
• Zhang Z, Dong Z, Dong W, Zhang T, Jia L, Dai H, Xing W. 2016. Interventional effects of the Chinese medicine Pu-Ren Dan on the expression of phosphorylated c-Jun amino-terminal kinase and cysteine aspartate kinase-3 in the retina of OLETF rats. Chinese Trad Patent Med. 38:1397–1401. (Chinese)
   Google Scholar
• Zhao HS, Shi XY, Wei WB, Wang NL. 2013. Effect of the regimen of Gaoshan Hongjingtian on the mechanism of poly (ADP-ribose) polymerase regulation of nuclear factor kappa B in the experimental diabetic retinopathy. Chin Med J (Engl). 126(9):1693–1699.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Yu J, Liu J, An X. 2016. The role of Liuwei Dihuang Pills and Ginkgo Leaf Tablets in treating diabetic complications. Evid Based Complement Alternat Med. 2016:7931314–7931318. doi: 10.1155/2016/7931314.
   PubMed Web of Science ®Google Scholar
• Zhao YQ, Li QS, Xiang MH, Zhang W, Zhang XR. 2017. Distribution of traditional Chinese medicine syndromes of diabetic retinopathy and correlation between symptoms. China J Trad Chinese Med Pharm. 42:2796–2801. (Chinese)
   Google Scholar
• Zhu X, Xie M, Wang K, Zhang K, Gao Y, Zhu L, Zhou F. 2014. The effect of puerarin against IL-1β-mediated leukostasis and apoptosis in retinal capillary endothelial cells (TR-iBRB2). Mol Vis. 20:1815–1823.
   PubMed Web of Science ®Google Scholar